Literature DB >> 23681650

Survival analysis of patients with chondrosarcomas of the pelvis.

Andreas F Mavrogenis1, Andrea Angelini, Gabriele Drago, Biagio Merlino, Pietro Ruggieri.   

Abstract

BACKGROUND: Studies for patients with pelvic chondrosarcomas are limited. This study determines the outcome of patients with pelvic chondrosarcomas, and whether there is any association with tumors' grade, type, stage, margins and pelvic location.
MATERIALS AND METHODS: We retrospectively studied 215 patients with pelvic chondrosarcomas. All patients had biopsy and histological diagnosis of their tumors followed by limb salvage or amputation. We staged patients using the Musculoskeletal Tumor Society system. We performed a univariate and multivariate analysis of the survival to death, local recurrence and metastasis with respect to grade, type (central vs. peripheral), stage, margins, and pelvic location, and the survival to death of patients with and without local recurrence.
RESULTS: Grade was the most important univariate and multivariate predictor of the survival of the patients. Dedifferentiation was associated with significantly lower overall survival. Peripheral chondrosarcomas predicted survival only in the univariate analysis. Surgical margins predicted local recurrence only in the multivariate analysis. Periacetabular location was associated with lower survival to death and local recurrence. The occurrence of local recurrence compromises the overall survival.
CONCLUSION: Grade was the most important predictor of the overall survival of patients with chondrosarcomas of the pelvis.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23681650     DOI: 10.1002/jso.23351

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  22 in total

Review 1.  State-of-the-art approach for bone sarcomas.

Authors:  Andreas F Mavrogenis; Andrea Angelini; Christos Vottis; Emanuela Palmerini; Eugenio Rimondi; Giuseppe Rossi; Panayiotis J Papagelopoulos; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-03

2.  What is the Proportion of Patients With Multiple Hereditary Exostoses Who Undergo Malignant Degeneration?

Authors:  Cory M Czajka; Matthew R DiCaprio
Journal:  Clin Orthop Relat Res       Date:  2015-01-13       Impact factor: 4.176

3.  Three-dimension-printed custom-made prosthetic reconstructions: from revision surgery to oncologic reconstructions.

Authors:  Andrea Angelini; Giulia Trovarelli; Antonio Berizzi; Elisa Pala; Anna Breda; Pietro Ruggieri
Journal:  Int Orthop       Date:  2018-11-22       Impact factor: 3.075

Review 4.  [Hemipelvectomy for pelvic sarcomas].

Authors:  W K Guder; J Hardes; M Nottrott; A Streitbürger
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

Review 5.  [Osteosarcoma and chondrosarcoma of the pelvis and lower extremities].

Authors:  W K Guder; J Hardes; G Gosheger; M Nottrott; A Streitbürger
Journal:  Chirurg       Date:  2015-10       Impact factor: 0.955

6.  Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.

Authors:  Hidetatsu Outani; Kenichiro Hamada; Yoshinori Imura; Kazuya Oshima; Tsukasa Sotobori; Yusuke Demizu; Shigeki Kakunaga; Susumu Joyama; Reiko Imai; Tomoaki Okimoto; Norifumi Naka; Ikuo Kudawara; Takafumi Ueda; Nobuhito Araki; Tadashi Kamada; Hideki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2015-07-07       Impact factor: 3.402

Review 7.  [Resection margins in bone tumors: what is adequate?].

Authors:  H R Dürr; Y Bakhshai; H Rechl; P-U Tunn
Journal:  Unfallchirurg       Date:  2014-07       Impact factor: 1.000

8.  Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.

Authors:  Annemiek van Maldegem; Anthony P Conley; Piotr Rutkowski; Shreyaskumar R Patel; Iwona Lugowska; Ingrid M E Desar; Judith V M G Bovée; Hans Gelderblom
Journal:  Oncologist       Date:  2018-08-06

9.  Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?

Authors:  Pablo D Roitman; Germán L Farfalli; Miguel A Ayerza; D Luis Múscolo; Federico E Milano; Luis A Aponte-Tinao
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

10.  Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma.

Authors:  William D Tap; Victor M Villalobos; Gregory M Cote; Howard Burris; Filip Janku; Olivier Mir; Murali Beeram; Andrew J Wagner; Liewen Jiang; Bin Wu; Sung Choe; Katharine Yen; Camelia Gliser; Bin Fan; Sam Agresta; Shuchi S Pandya; Jonathan C Trent
Journal:  J Clin Oncol       Date:  2020-03-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.